Tag: IVL

Disrupt PAD III

Shockwave IVL maintains superiority to angioplasty in calcified peripheral disease at...

Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to...

Confined by the complexity of calcium? Expand the boundaries with Shockwave...

This educational supplement is only available in selected countries and geographies. In this supplement, sponsored by Shockwave Medical: Marianne Brodmann (Medical University of...

Shockwave Medical announces global launch of new peripheral IVL catheter

Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both CE mark and US...

CX 2022 highlights new data in the vascular world

Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...

Vascular community needs a “clear strategy” for treating severely calcified lesions

 Said Abisi (London, UK) talks to Vascular News about the various treatment options for peripheral arterial disease (PAD) patients with severely calcified lesions, including...
IVL

Cardiovascular Systems announces development of IVL technology for the treatment of...

Cardiovascular Systems recently announced that it has made significant progress towards the commercialisation of intravascular lithotripsy (IVL) systems for the treatment of calcific coronary...
IVL

Shockwave Medical enrols first patient in Disrupt BTK II study for...

Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the...
IVL

CMS increases hospital outpatient payment for peripheral intravascular lithotripsy

Shockwave Medical has announced that, as part of the calendar year 2022 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule, the Centers for...

VIVA 2021: IVL “consistently” treats real-world calcium in multiple peripheral vessel...

An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL; Shockwave Medical) performs “consistently well” across challenging peripheral vessels,...